The drive to find a vaccine to combat the coronavirus is well underway. Several large pharmaceutical and smaller biotech companies are working on making new antibodies, drugs and vaccines to combat the coronavirus disease but lack of funds may yet get in the way, writes John Whelan.

The global over-reaction to coronavirus has again exposed a lack of preparedness that will persist unless we spend as much on health as on weapons, says Julie Sunderland